A double-blind, placebo-controlled dose-response comparison of intramuscular olanzapine and haloperidol in the treatment of acute agitation in schizophrenia.

Breier, Alan; Meehan, Karena; Birkett, Martin; David, Stacy; Ferchland, Iris; Sutton, Virginia; C Taylor, Cindy; Palmer, Rebecca; Dossenbach, Martin; Kiesler, Geri; Brook, Shlomo; Wright, Padraig

doi:10.1001/archpsyc.59.5.441

Public

A double-blind, placebo-controlled dose-response comparison of intramuscular olanzapine and haloperidol in the treatment of acute agitation in schizophrenia.

Shared by NobleBlocks on May 1, 2002 • 12:00 AM UTC

Authors:

Alan Breier

Karena Meehan

Martin Birkett

Abstract

BACKGROUND: An intramuscular (IM) formulation of olanzapine has been developed because there are no rapid-acting IM atypical antipsychotic drugs currently available in the United States for treating acute agitation in patients with schizophrenia. METHODS: Recently hospitalized acutely agitated patie...

Discussions